Beone Medicines Ltd. Class A · SSE:688235
Ball Titus B. sold 169 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Ball Titus B. (Principal Accounting Officer) sold 169 Beone Medicines Ltd. Class A shares at an average US$257.20 for US$43,467, leaving 0 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 169 shares
- Price
- US$257.20 average (US$256.39 to US$257.53)
- Value
- US$43,467
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ordinary Shares | Award | 31,213 | 99,645 | Direct | |
| Jun 11, 2026 | American Depositary Shares | Sale | 49 | US$256.39 | 120 | Direct |
| Jun 11, 2026 | American Depositary Shares | Sale | 120 | US$257.53 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Ball Titus B.
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Ball Titus B. · Sep 3, 2026
- Form 4 · Ball Titus B. · Jun 10, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026